Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by CHELLMAN, G. J.
Right arrow Articles by MCCULLOUGH, T. E.
Right arrow Search for Related Content
PubMed
Right arrow Articles by CHELLMAN, G. J.
Right arrow Articles by MCCULLOUGH, T. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 Oxford University Press

other

Rat Paw-Lick/Muscle Irritation Model for Evaluating Parenteral Formulations for Pain-on-Injection and Muscle Damage1

GARY J. CHELLMAN2, GEORGE F. FAUROT3, LANCE O. LOLLINI{dagger} and TIM E. MCCULLOUGH*

{dagger}Department of Pathology, Institute of Toxicologic Sciences Syntex, Inc., Palo Alto, California 94303 *Department of Toxicology Syntex, Inc., Palo Alto, California 94303

Received April 23, 1990; accepted July 24, 1990

Rat Paw-Lick/Muscle Irritation Model for Evaluating Parenteral Formulations for Pain-on-Injection and Muscle Damage. CHELLMAN, G. J., FAUROT, G. F., LOLLINI, L. O., AND MCCULLOUGH, T. E. (1990). Fundam. Appl. Toxicol. 15, 697–709. A two-phase assay was developed in the rat to evaluate parenteral formulations intended for intramuscular administration for the induction of both acute pain-on-injection and delayed pain/discomfort at the injection site (secondary to muscle damage). Phase 1 of the assay assessed pain-on-injection using a modified version of the previously published rat paw-lick assay. Adult male CD rats (10/group) were given subplantar (footpad) injections of 0.1 ml and then observed for 15 min for paw-lick responses. To increase assay sensitivity, responses more subtle than paw licks (ie., paw lifts) were scored, and injection-site clinical signs were recorded 6, 24, and 48 hr after injection. Phase 2 of the assay assessed myotoxic potential, using the same rats after a 1-week recovery period. The rats were injected intramuscularly in the anterior thigh with 0.2 ml, bled from the orbital sinus at 2, 6, and 24 hr for analysis of serum creatine kinase (CK), and then necropsied at 24 hr to prepare tissue sections of the injection site for microscopic examination. A series of cephalosporin-type antibiotics produced pain-on-injection and muscle damage consistent with reported clinical experience (cefazolin < cephalothin < cefoxitin). Several nonantibiotic parenteral formulations (diazepam, digoxin, phenytoin, and lidocaine) tested in the paw-lick/muscle irritation model also produced responses that correlated with the clinic, i.e., virtually no acute pain but moderate to marked muscle damage. The results indicate that the two-phase rat paw-lick/muscle irritation model is effective in evaluating parenteral formulations for clinical acceptability, and that both phases of the assay are necessary to optimize predictability of the assay for human clinical experience.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.